Premature drug reduction after subthalamic nucleus deep brain stimulation leading to worse depression in patients with Parkinson's disease
BackgroundReduction of medication in Parkinson's disease (PD) following subthalamic nucleus deep brain stimulation (STN-DBS) has been recognized, but the optimal timing for medication adjustments remains unclear, posing challenges in postoperative patient management.ObjectiveThis study aimed to...
Main Authors: | Yu Diao, Tianqi Hu, Hutao Xie, Houyou Fan, Fangang Meng, Anchao Yang, Yutong Bai, Jianguo Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-10-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2023.1270746/full |
Similar Items
-
A Meta-Analysis of the Effect of Subthalamic Nucleus-Deep Brain Stimulation in Parkinson's Disease-Related Pain
by: Yu Diao, et al.
Published: (2021-07-01) -
Effects of Subthalamic Nucleus Deep Brain Stimulation on Depression in Patients with Parkinson’s Disease
by: Tianqi Hu, et al.
Published: (2022-10-01) -
Profiling the low-beta characteristics of the subthalamic nucleus in early- and late-onset Parkinson’s disease
by: Delong Wu, et al.
Published: (2023-02-01) -
Subthalamic nucleus deep brain stimulation alleviates oxidative stress via mitophagy in Parkinson’s disease
by: Yingchuan Chen, et al.
Published: (2024-03-01) -
Low-frequency oscillations link frontal and parietal cortex with subthalamic nucleus in conflicts
by: Quan Zhang, et al.
Published: (2022-09-01)